--- title: 'Manufacturing Daily Summary: What Happened on October 5, 2026' headline: Bayer plans $2.2 billion Ohio manufacturing site description: The facility is scheduled to start production in stages in 2031 and 2034. Biogen is also spending on its North Carolina expansion. url: https://thebench.bio/news/manufacturing/2026-10-05 topic: manufacturing date: '2026-10-05' covers: - '2026-10-05' date_published: '2026-10-05T12:02:03Z' date_modified: '2026-10-05T12:02:03Z' sources: 2 publisher: The Bench (thebench.bio) --- # Manufacturing Daily Summary: What Happened on October 5, 2026 **Bayer plans $2.2 billion Ohio manufacturing site** The facility is scheduled to start production in stages in 2031 and 2034. Biogen is also spending on its North Carolina expansion. ## Today in brief Bayer plans a $2.2 billion pharmaceutical plant at New Albany International Business Park in Ohio. [1] The company estimates construction will generate nearly 1,500 jobs, with about 600 roles at the operating site. [1] ## Bayer plans Ohio site with production starting in 2031 Bayer plans to build a $2.2 billion pharmaceutical manufacturing facility at New Albany International Business Park. [1] The modular site would make drug substances, the active ingredients in medicines, and finished drug products, using automated and digital systems. [1] Bayer plans to open the first drug-substance module in 2031 and a drug-product unit in 2034. [1] The facility is intended to support medicines in cardiovascular, cancer, and kidney care. [1] Construction is expected to create nearly 1,500 jobs. The operating site is projected to support about 600 roles. [1] ## Also worth knowing - Biogen executive Nicole Murphy said the company had executed about $200 million year-to-date in 2026 toward its previously announced $2 billion Research Triangle Park expansion, including an antisense oligonucleotide purification facility and added synthesis capacity. [2] ## The day in numbers - **$2.2 billion**: Bayer's planned investment in its Ohio pharmaceutical manufacturing site. [1] - **2031 and 2034**: Bayer's planned opening dates for the drug-substance and drug-product units, respectively. [1] ## Also published - [How AI is transforming biopharma manufacturing facilities of the future](), BioPharma Dive - [Designing biologics for commercial success](), European Biotechnology - [Notable TechBio startups and companies operating in Philippines](), MetaphysicalCells - [Bayer pledges $2.2bn to US manufacturing facility](), pharmaphorum ## Sources 1. [Bayer plans $2.2bn pharmaceutical manufacturing facility in Ohio, US](), Pharmaceutical Technology, 2026-10-05 2. [BIO on the American Road visits pioneering NC biotech hub](), Bio.News, 2026-10-05 --- The Bench wrote this from the reporting cited above, with a language model drafting and editing. [1]: [2]: